Why Oddity Tech ($ODD (Oddity Tech Ltd))’s Current Valuation May Present an Opportunity
Company Overview
Oddity Tech Ltd. ($ODD), founded in 2018 and headquartered in Tel Aviv with New York operations, is an AI-driven consumer tech platform transforming beauty and wellness. It uses AI, molecular discovery, and data science to scale brands like IL MAKIAGE (personalized makeup) and SpoiledChild (wellness supplements). With over 50 million users and 2 billion+ data points, Oddity's closed-loop system enables hyper-personalization, low returns, and high loyalty. IPO'd on NASDAQ in July 2023, it disrupts legacy players like Estée Lauder via deep AI integration.
Recent Performance and 2025 Guidance
In 2025, Oddity exceeded expectations, raising guidance multiple times. Q3 net revenue hit $148M (+24% YoY), with adjusted EPS of $0.40 (beating forecasts by 14%). Gross margins rose to 71.6% (+170 bps). Q2 revenue was $241M. Full-year 2025 revenue forecast: ~$770M. Analysts expect 20%+ growth through 2027, reaching $1.3B by 2028. Q4 EPS guidance: $0.11–$0.13.
Key Strategies for Growth
Oddity's DTC model drives 73% gross margins and rich customer data for innovation. New 2025 brands: METHODIQ (telehealth dermatology with proprietary molecules like Fibroquin, launched Nov. 2025). Brand 4 forthcoming. ODDITY LABS plans 8+ products in 2026. Strategies include international expansion, AI-optimized launches, and a $350M credit facility for scaling.
Challenges and Risks
Volatility persists: 13% stock drop post-Q2 despite beats. Leadership changes (e.g., CSO exit) and institutional selling (e.g., Baillie Gifford) raise concerns. Competition from AI-investing giants, regulatory hurdles for telehealth, market saturation, supply issues, and economic sensitivity threaten growth. Projected 15.9% annual revenue growth could falter on launch misses. Stock below $40 reflects uncertainties.
Valuation
As of Jan. 23, 2026, shares at $35.42; market cap ~$2.03B. P/E: 19.79; EV/EBITDA: 15.19. DCF suggests undervalued by 47% (intrinsic ~$66). Analyst target: $62 (75% upside); ratings include "Overweight" and "Strong Buy." Expected earnings/revenue growth: 17.3%/15.9%. High hedge fund interest signals opportunity.
Overall Summary
Oddity ($ODD) excels in AI-driven beauty/wellness with strong 2025 results, new brands like METHODIQ, and scalable margins. Risks include execution and competition, but undervalued shares offer upside for long-term investors in tech-disrupted consumer markets. Conduct due diligence amid volatility.... Show More
Not investment advice. The author may have financial interests in the mentioned instruments.
1
0
0
.
We use our own and third-party cookies on our websites to enhance your experience, analyze traffic, and for security and marketing. For more info, see our Cookie Policy or go to Manage Settings.
Privacy Preference Center
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
More information
Manage Consent Preferences
Strictly Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Cookie List
label
ConsentLeg.Interest
label
label
label
Sun May 17 2026 12:22:23 GMT+0000 (Coordinated Universal Time)
